The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic profiling in a subgroup analysis of patients (pts) with diffuse large B-cell lymphoma (DLBCL) and extranodal (EN) sites of involvement in the phase 3 Pola-R-CHP versus R-CHOP (POLARIX) study.
 
Jennifer Kimberly Lue
Stock and Other Ownership Interests - Araclon Biotech
Consulting or Advisory Role - ADC Therapeutics; Genentech; Merck Sharp & Dohme
Research Funding - Kymera
 
Franck Morschhauser
Honoraria - AstraZeneca; Chugai Foundation for Innovative Drug Discovery Science; Takeda
Consulting or Advisory Role - Abbvie; BMS Brazil; Gilead Sciences; Modex Therapeutics; Novartis; Roche
Expert Testimony - Roche
 
Herve Tilly
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - ADC Therapeutics; Celgene/Bristol-Myers Squibb; Roche
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Janssen
 
Georg Lenz
Honoraria - Abbvie; ADC Therapeutics; AstraZeneca; Bristol-Myers Squibb; Constellation Pharmaceuticals; Genmab/Seattle Genetics; Gilead Sciences; Incyte; Janssen-Cilag; Novartis; Roche/Genentech; SOBI
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Bristol-Myers Squibb; Genase Therapeutics; Genmab/Seattle Genetics; Gilead Sciences; Hexal; Immagene; Incyte; Janssen-Cilag; Karyopharm Therapeutics; Lilly; Miltenyi Biomedicine; MorphoSys; Novartis; PentixaPharm; Roche/Genentech; Sobi
Research Funding - AGIOS; Aquinox; AstraZeneca; Bayer; Gilead Sciences; Janssen-Cilag; MorphoSys; Roche/Genentech; Verastem
Expert Testimony - Roche
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen-Cilag; Roche/Genentech
 
Fabrice Jardin
Honoraria - Abbvie/Genentech; Abbvie/Genentech; Celgene; Janssen; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Roche
 
Alex Francisco Herrera
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Adicet Bio; Alimera Sciences; AstraZeneca/MedImmune; Bristol-Myers Squibb; Caribou Biosciences; Genentech/Roche; Genmab; Karyopharm Therapeutics; Merck; Pfizer; Regeneron; Seagen; Takeda; Tubulis GmbH
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Kite, a Gilead company (Inst); Merck (Inst); Seagen (Inst)
 
Jeff Porter Sharman
Employment - US Oncology Network
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Beigene; Bristol-Myers Squibb; Genentech; Janssen Oncology; Lilly; Merck
 
Christopher Flowers
Stock and Other Ownership Interests - Foresight Diagnostics; N Power
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb/Celgene; Celgene; Curio Science; Denovo Biopharma; Epizyme; Foresight Diagnostics; Genentech/Roche; Genmab; Gilead Sciences; Karyopharm Therapeutics; MorphoSys; Pharmacyclics/Janssen; SeaGen; Spectrum Pharmaceuticals
Research Funding - 4D Pharma (Inst); Abbvie (Inst); Acerta Pharma (Inst); Adaptimmune (Inst); Alimera Sciences (Inst); Amgen (Inst); Bayer (Inst); Celgene (Inst); Cellectis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Guardant Health (Inst); Iovance Biotherapeutics (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Millennium (Inst); MorphoSys (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Sanofi (Inst); Takeda (Inst); TG Therapeutics (Inst); Xencor (Inst); ZIOPHARM Oncology (Inst)
 
Jonathan W. Friedberg
Research Funding - Enterome (Inst)
Patents, Royalties, Other Intellectual Property - Patient on bone marrow microenvironment signals (I)
 
Marek Trneny
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Janssen; MorphoSys; Novartis; Roche; SOBI; Swixx BioPharma; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Autolus; Bristol-Myers Squibb; Caribou Biosciences; Genmab; Gilead Sciences; Incyte; Janssen; MorphoSys; Novartis; Roche; SOBI; Takeda
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Gilead Sciences; janssen; Roche; SOBI; Takeda
 
Charles Herbaux
Honoraria - Abbvie; Gilead Sciences; Janssen-Cilag; Roche
Research Funding - Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Janssen-Cilag; Roche
 
Mark Yan
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Yanwen Jiang
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Patents, Royalties, Other Intellectual Property - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Jamie Hirata
Employment - TBC
 
Connie Lee Batlevi
Employment - F. Hoffmann-La Roche/Genentech, Inc.
Stock and Other Ownership Interests - Moderna Therapeutics; Regeneron; Roche
Consulting or Advisory Role - AbbVie; ADC Therapeutics; Bristol-Myers Squibb; Genentech; Karyopharm Therapeutics; Kite, a Gilead Company; Seagen; TG Therapeutics; Treeline Biosciences
Research Funding - Autolus; Epizyme; Roche; Vincerx Pharma
 
Deniz Sahin
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche
 
Wilfred Leung
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
 
Will Harris
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Patents, Royalties, Other Intellectual Property - Genentech
Travel, Accommodations, Expenses - Genentech
 
Gilles A. Salles
Stock and Other Ownership Interests - Owkin
Honoraria - Abbvie; Incyte
Consulting or Advisory Role - Abbvie; ATB Therapeutics; BeiGene; BMS; Debiopharm Group; Epizyme; Genmab; incyte; Incyte; Ipsen; Janssen; Kite/Gilead; Loxo/Lilly; Merck; Molecular Partners; morphosys; Nordic Nanovector; Novartis; Nurix; Orna Therapeutics; Roche/Genentech
Research Funding - 920 (Inst); Ipsen (Inst); Janssen (Inst)
 
Laurie Helen Sehn
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Celgene/Bristol-Myers Squibb; Genmab; Gilead Sciences; Incyte; Janssen-Ortho; Kite, a Gilead company; Merck; Roche/Genentech; Sandoz-Novartis; Seagen; Teva
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Beigene; Celgene/Bristol-Myers Squibb; Genmab; Gilead Sciences; Incyte; Janssen; Kite, a Gilead company; Merck; Roche/Genentech; Sandoz-Novartis; Seagen; Teva; TG therapeutics
Research Funding - Roche/Genentech (Inst); Teva (Inst)